Outcome Evaluation of Minority AIDS Initiative Programs in the New York EMA

  • STATUS
    Recruiting
  • participants needed
    5100
  • sponsor
    The New York Academy of Medicine
Updated on 7 November 2020
AIDS

Summary

This outcome evaluation effort provides the opportunity to learn what programmatic approaches effectively address two of the most difficult hurdles in HIV health services delivery: (1) getting people who would benefit from health care to use it and (2) getting people who do use health care to do so more consistently and effectively. The New York HIV Planning Council (through MHRA) has funded 23 agencies to achieve these objectives for people of color with HIV disease.

Description

All clients are assessed upon entry into the program, have their service utilization tracked, and then are reassessed at three, six, and twelve months following program entry. The main client-level data elements collected during baseline and follow-up interviews are the following: - Biological markers (including HIV status, viral load, t-cell count) - Demographic characteristics - Adherence to treatment - Barriers to care - Social support - Substance use and treatment - Functional health status Functional Health Status is used in this evaluation as the primary measure of final client “outcomes.” The Functional Health Status items we use are from the ACTG SF-21 (a modified version of the Medical Outcomes Study instrument). The overall evaluation objectives are to: - Describe the change in functional health status for different populations and groups of clients. - Identify services or constellations of services and intensity of services associated with change in functional health status. - Assess whether programs meet intermediate objectives (decreased drug use, increased service use, improved housing stability). - Identify barriers to access to and maintenance in care.

Details
Condition HIV infection
Treatment Maintenance in Care Services, Access to Care Services
Clinical Study IdentifierNCT00273403
SponsorThe New York Academy of Medicine
Last Modified on7 November 2020

Eligibility

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note